In a letter to US president Donald Trump, the Association for Accessible Medicines – along with a host of other pharmaceutical and healthcare bodies and associations – has urged the administration to not implement policies that “restrict access to, or destabilize the supply chain for, currently available pharmaceuticals or medical devices.”
AAM Urges Trump Not To Destabilize Supply Chain
Warns ‘Buy American’ Changes Could Hinder COVID-19 Pandemic Response
The AAM has warned the Trump administration that ‘Buy American’ requirements on medicines could limit patient access to affordable medicines and increase the risk of drug shortages during the coronavirus pandemic.
